fluticasone / salmeterol

Known as: fluticasone-salmeterol, FLUTICASONE/SALMETEROL, Fluticasone Salmeterol Combination 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND Most guidelines recommend either a long-acting beta-agonist (LABA) plus an inhaled glucocorticoid or a long-acting… (More)
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND QVA149 is an inhaled fixed-dose combination therapy under development for the treatment of chronic obstructive… (More)
Is this relevant?
2010
2010
BACKGROUND A proof-of-concept study suggested that combination therapy with commercial azelastine hydrochloride nasal spray and… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Guidelines recommend inhaled corticosteroids (ICS) as maintenance treatment for patients with chronic obstructive… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
This 12-month dose-titration study assessed the effectiveness of budesonide/formoterol for maintenance plus relief with a control… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
STUDY OBJECTIVES To compare the efficacy and safety of the inhaled corticosteroid fluticasone propionate (FP) and the inhaled… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
STUDY OBJECTIVES To compare the lung deposition of radiolabeled hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP) with… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Chronic obstructive pulmonary disease (COPD) is a condition in which continuous bronchodilation may have clinical advantages… (More)
Is this relevant?
2001
2001
AIMS To determine the basal pharmacokinetics, lung uptake and plasma cortisol suppression for two commonly prescribed inhaled… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
STUDY OBJECTIVES To examine and compare the efficacy and safety of salmeterol xinafoate, a long-acting inhaled beta2-adrenergic… (More)
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?